The Patent Finder

Philogen S.P.A.

Also on record
Records under this name other than the patents Philogen S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.

Back to Philogen S.P.A.

PatentTitleStatus Expires Confidence
US 11,390,666Vascular Endothelial Growth Factor/Anti-Fibronectin Antibody Fusion Proteins
Lapsed on the fee record
Ended Jul 19, 2026 · High confidence
Lapsed on the fee recordEnded Jul 19, 2026High confidence
US 8,679,488Targeting of Bone Marrow Neovasculature
Lapsed on the fee record
Ended Mar 25, 2026 · High confidence
Lapsed on the fee recordEnded Mar 25, 2026High confidence
US 8,481,684Novel Antigen Associated with the Neovasculature of Tumour Metastases
Term ended
Term ended Mar 7, 2026 · Medium confidence
Term endedTerm ended Mar 7, 2026Medium confidence
US 9,896,503Novel Antigen Associated with the Neovasculature of Tumour Metastases
Term ended
Term ended Mar 7, 2026 · Low confidence
Term endedTerm ended Mar 7, 2026Low confidence
US 8,455,625Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12
Lapsed on the fee record
Ended Jun 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 4, 2025From the USPTO record
US 10,906,963Non-glycosylated anti-tenascin antibody
Lapsed on the fee record
Ended Feb 2, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 2, 2025From the USPTO record
US 9,549,981Sequential antibody therapy
Lapsed on the fee record
Ended Jan 24, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 24, 2025From the USPTO record
US 8,344,177Albumin binding molecules and uses thereof
Formerly held
Lapsed on the fee record
Ended Jan 1, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 1, 2025From the USPTO record
US 9,527,907Antigens associated with endometriosis, psoriatic arthritis and psoriasis
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 10,858,411IL22 Immunoconjugates
Lapsed on the fee record
Ended Dec 8, 2024 · High confidence
Lapsed on the fee recordEnded Dec 8, 2024High confidence
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited